Dr. Jordan Smith Presented at the Society for Fetal Urology Meeting
Dr. Jordan Smith presented her research on “Congenital Giant Megaureter", at the Society for Fetal Urology Meeting held in Houston, TX on September 21, 2023.
Dr. Jordan Smith presented her research on “Congenital Giant Megaureter", at the Society for Fetal Urology Meeting held in Houston, TX on September 21, 2023.
The UF Department of Urology is very excited to welcome four bright and talented faculty who have joined our esteemed group. This represents one of the largest recruitment years in the past decade of our program and is indicative of the growth and success of our department. Each has received unique advanced fellowship training and with these four new hires, we have deepened the 'bench' of our comprehensive urologic subspecialty offerings.
The University of Florida Department of Urology once again showcased its commitment to academic and clinical excellence at the 75th Annual Meeting of the FUS, held from August 31 - September 3, 2023, at the Loews Sapphire Falls Resort in Orlando. Our residents and faculty were at the forefront, contributing significantly to the event's success.
Call for appointment (352) 265-8240.
Core Lecture: "Supine PCNL" Monday, 8/21/23 UF Urology Conference Room M203 C
Join us Tuesday, August 22nd from 7:00 pm - 8:00 pm ET for our 2023 UF Urology Residency Program Open House!
The UF Department of Urology is thrilled to announce the addition of its newest UroGator, Dr. Joshua Heiman, after matching into the UF Urology 2024 – 2025 Endourology/MIS Fellowship.
Core Lecture: "Priapism" | Tuesday, August 8, 2023 | 7:00 am | Urology Conference Room, M2-203C | Email Stephanie Stenner for Zoom information
Learn more about “Ureteral Stents: A Brief Overview on Indications and Options” with Trisha Nguyen, MD | Thursday, August 3, 2023
William Donelan, Ph.D., a research assistant scientist in the department of urology in the UF College of Medicine, was awarded a grant for his project, titled “Novel antibody-drug conjugates for the treatment of bladder cancer.” This project seeks to develop a new class of antibody-drug conjugates that can selectively target and kill bladder cancer cells, while sparing healthy tissues.